Fecal Eosinophil-Derived Neurotoxin (EDN) as a Diagnostic and Disease Progression Marker in Eosinophilic Gastrointestinal Diseases

Yuichi Taniyama, Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Suzu, Ishikawa, Japan; Masaaki Usami, Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa city, Ishikawa, Japan; Hanae Miyazawa, Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan., Kanazawa, Ishikawa, Japan; Yusuke Matsuda, Kanazawa University, Kanazawa, Ishikawa, Japan; Tetsujiro Shirahashi, Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan., Kanazawa, Ishikawa, Japan; Tomoko Toma, Department of Pediatrics, Kanazawa University, Kanazawa, Ishikawa, Japan; Taizo Wada, Kanazawa University, Kanazawa, Ishikawa, Japan